Trials / Recruiting
RecruitingNCT07423650
Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy
Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy: A Randomized Controlled Double-Blind Trial
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 93 (estimated)
- Sponsor
- Iuliu Hatieganu University of Medicine and Pharmacy · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to determine whether continuous nefopam administration, as part of a multimodal analgesia strategy, reduces opioid consumption and improves patient satisfaction after pancreatoduodenectomy. The main questions are: Does nefopam administration reduce opioid consumption after pancreatoduodenectomy? Does nefopam administration reduce postoperative pain levels after pancreatoduodenectomy? Researchers will compare two other analgesic strategies, namely continuous lidocaine infusion and epidural analgesia, to assess whether they lead to better outcomes. Participants will complete the QoR-15 questionnaire and report their pain levels at predefined time points before and after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nefopam 120mg/day infusion | Nefopam administration will start in the intraoperative period and continue for 48 hours in the postoperative period |
| DRUG | Lidocaine Infusion | Lidocaine infusion will begin in the intraoperative period and continue in the postoperative period for 48 hours |
| DRUG | Peridural | This group will receive the stardad practice in our hospital, peridural analgesia alongside a multimodal analgesic approach involving paracetamol 4g/day |
| DRUG | Multimodal IV analgesia | Standard postoperative multimodal pain management regimen |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2026-02-20
- Last updated
- 2026-03-24
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT07423650. Inclusion in this directory is not an endorsement.